Work

Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC

Year: 2017

Type: article

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-017-2099-3

Authors: Jürgen C. Becker, Andreas Stang, Axel zur Hausen, Nicole Fischer, James A. DeCaprio, Richard W. Tothill, Rikke Lyngaa, Ulla Kring Hansen, Cathrin Ritter, Paul Nghiem, Christopher K. Bichakjian, Selma Ugurel, David Schrama

Institutions: German Cancer Research Center, Essen University Hospital, Institut für Medizinische Informatik, Biometrie und Epidemiologie, Stiftung Universitätsmedizin Essen, Maastricht University Medical Centre, University Medical Center Hamburg-Eppendorf, Harvard University, Dana-Farber Cancer Institute, Peter MacCallum Cancer Centre, Technical University of Denmark, University of Washington, University of Michigan, Universitätsklinikum Würzburg

Language: English

Topic: Polyomavirus and related diseases

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: European Commission, National Cancer Institute

Awards: Human Cancer Suppressor Functions of Protein Phosphatase 2A, IMmune MOdulating strategies for treatment of MErkel cell Carcinoma, Pathogenetic and prognostic studies for improved therapy of Merkel cell carcinoma, Viral oncoprotein targeted immune therapy for Merkel cell carcinoma, G5843292180, Papova Virus Transforming Mechanisms, RB-Related Proteins and Polyomavirus Large T antigen Transformation

OpenAlex ID: W2769847897

FWCI: 4.634

Cites: 61

Cited by: 112

Related to: 10